144 related articles for article (PubMed ID: 33012144)
1. Current status and comparison of national health insurance systems for advanced radiation technologies in Korea and Japan.
Huh SJ; Nishimura T; Park W; Onishi H; Ahn YC; Nakamura K
Radiat Oncol J; 2020 Sep; 38(3):170-175. PubMed ID: 33012144
[TBL] [Abstract][Full Text] [Related]
2. Survey of advanced radiation technologies used at designated cancer care hospitals in Japan.
Shikama N; Tsujino K; Nakamura K; Ishikura S
Jpn J Clin Oncol; 2014 Jan; 44(1):72-7. PubMed ID: 24174632
[TBL] [Abstract][Full Text] [Related]
3. A newly introduced comprehensive consultation fee in the national health insurance system in Japan: a promotive effect of multidisciplinary medical care in the field of radiation oncology--results from a questionnaire survey.
Igaki H; Onishi H; Nakagawa K; Dokiya T; Nemoto K; Shigematsu N; Nishimura Y; Hiraoka M;
Jpn J Clin Oncol; 2013 Dec; 43(12):1233-7. PubMed ID: 24068710
[TBL] [Abstract][Full Text] [Related]
4. Clinical utilization of radiation therapy in Korea, 2016.
Kim E; Jang WI; Kim MS; Paik EK; Kim HJ; Yoo HJ; Yang K; Cho CK
J Radiat Res; 2020 Mar; 61(2):249-256. PubMed ID: 31913473
[TBL] [Abstract][Full Text] [Related]
5. Comparison of radiotherapy infrastructure between Korea and Japan.
Huh SJ; Nishimura T; Park W; Nakamura K
Jpn J Clin Oncol; 2019 Dec; 49(11):1024-1028. PubMed ID: 31665340
[TBL] [Abstract][Full Text] [Related]
6. Health insurance systems in Japan: a neurosurgeon's view.
Ito M
Neurol Med Chir (Tokyo); 2004 Dec; 44(12):617-28. PubMed ID: 15684593
[TBL] [Abstract][Full Text] [Related]
7. A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy.
Rim CH; Lee J; Kim WC; Yang D; Yoon WS; Koom WS; Kim CY
J Korean Med Sci; 2018 Feb; 33(9):e67. PubMed ID: 29441739
[TBL] [Abstract][Full Text] [Related]
8. Current Medical Technology Reimbursement System in Japan.
Matsumoto T; Strachan L; Oyama S; Ishiguro Y; Lee SS
Value Health Reg Issues; 2023 Mar; 34():118-124. PubMed ID: 36696768
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in intensity-modulated radiation therapy use in Korea.
Huh SJ; Park W; Choi DH
Radiat Oncol J; 2019 Dec; 37(4):249-253. PubMed ID: 31918461
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
[TBL] [Abstract][Full Text] [Related]
12. [Changes in national insurance reimbursement with introduction of the DPC package payment system for 131I therapy for hyperthyroidism].
Watanabe S; Kosuda S; Yano F; Abe K; Kusano S; Tanaka Y
Kaku Igaku; 2004 Nov; 41(4):415-9. PubMed ID: 15690770
[TBL] [Abstract][Full Text] [Related]
13. Current status of the infrastructure and characteristics of radiation oncology in Korea.
Huh SJ;
Jpn J Clin Oncol; 2007 Aug; 37(8):623-7. PubMed ID: 17673472
[TBL] [Abstract][Full Text] [Related]
14. Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in Japan.
Nakamura K; Akimoto T; Mizowaki T; Hatano K; Kodaira T; Nakamura N; Kozuka T; Shikama N; Kagami Y
Jpn J Clin Oncol; 2012 Jan; 42(1):53-7. PubMed ID: 22131339
[TBL] [Abstract][Full Text] [Related]
15. [Current status and limitation of particle radiation therapy].
Ogino T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1801-5. PubMed ID: 19920381
[TBL] [Abstract][Full Text] [Related]
16. Why screening rates vary between Korea and Japan--differences between two national healthcare systems.
Goto R; Hamashima C; Mun S; Lee WC
Asian Pac J Cancer Prev; 2015; 16(2):395-400. PubMed ID: 25684461
[TBL] [Abstract][Full Text] [Related]
17. [Problems of national health insurance reimbursement revision, especially for laboratory tests].
Mori M
Rinsho Byori; 1995 Jul; 43(7):660-4. PubMed ID: 7674537
[TBL] [Abstract][Full Text] [Related]
18. Japanese structure survey of high-precision radiotherapy in 2012 based on institutional questionnaire about the patterns of care.
Tomita N; Kodaira T; Teshima T; Ogawa K; Kumazaki Y; Yamauchi C; Toita T; Uno T; Sumi M; Onishi H; Kenjo M; Nakamura K
Jpn J Clin Oncol; 2014 Jun; 44(6):579-86. PubMed ID: 24729623
[TBL] [Abstract][Full Text] [Related]
19. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group.
Nagata Y; Hiraoka M; Mizowaki T; Narita Y; Matsuo Y; Norihisa Y; Onishi H; Shirato H
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):343-7. PubMed ID: 19735861
[TBL] [Abstract][Full Text] [Related]
20. Adoption of Radiation Technology Among Privately Insured Nonelderly Patients With Cancer in the United States, 2008 to 2014: A Claims-Based Analysis.
Pan HY; Jiang J; Shih YT; Smith BD
J Am Coll Radiol; 2017 Aug; 14(8):1027-1033.e2. PubMed ID: 28408078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
